rs148129382

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_031407.7(HUWE1):​c.654T>C​(p.Ser218Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000803 in 1,186,695 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 306 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., 14 hem., cov: 22)
Exomes 𝑓: 0.00083 ( 0 hom. 292 hem. )

Consequence

HUWE1
NM_031407.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.33

Publications

0 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
HUWE1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked syndromic, Turner type
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant X-53631606-A-G is Benign according to our data. Variant chrX-53631606-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211169.
BP7
Synonymous conserved (PhyloP=1.33 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000536 (60/111952) while in subpopulation NFE AF = 0.000885 (47/53096). AF 95% confidence interval is 0.000683. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 60 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HUWE1NM_031407.7 linkc.654T>C p.Ser218Ser synonymous_variant Exon 10 of 84 ENST00000262854.11 NP_113584.3 Q7Z6Z7-1A0A024R9W5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HUWE1ENST00000262854.11 linkc.654T>C p.Ser218Ser synonymous_variant Exon 10 of 84 1 NM_031407.7 ENSP00000262854.6 Q7Z6Z7-1

Frequencies

GnomAD3 genomes
AF:
0.000536
AC:
60
AN:
111899
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000650
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000474
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000372
Gnomad FIN
AF:
0.000491
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000885
Gnomad OTH
AF:
0.00132
GnomAD2 exomes
AF:
0.000552
AC:
101
AN:
182973
AF XY:
0.000578
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000563
Gnomad NFE exome
AF:
0.000991
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.000831
AC:
893
AN:
1074743
Hom.:
0
Cov.:
27
AF XY:
0.000850
AC XY:
292
AN XY:
343587
show subpopulations
African (AFR)
AF:
0.0000770
AC:
2
AN:
25964
American (AMR)
AF:
0.000228
AC:
8
AN:
35162
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19220
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30112
South Asian (SAS)
AF:
0.000149
AC:
8
AN:
53524
European-Finnish (FIN)
AF:
0.000913
AC:
37
AN:
40518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3275
European-Non Finnish (NFE)
AF:
0.000982
AC:
807
AN:
821667
Other (OTH)
AF:
0.000684
AC:
31
AN:
45301
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000536
AC:
60
AN:
111952
Hom.:
0
Cov.:
22
AF XY:
0.000410
AC XY:
14
AN XY:
34130
show subpopulations
African (AFR)
AF:
0.0000648
AC:
2
AN:
30842
American (AMR)
AF:
0.000473
AC:
5
AN:
10571
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.000373
AC:
1
AN:
2682
European-Finnish (FIN)
AF:
0.000491
AC:
3
AN:
6112
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000885
AC:
47
AN:
53096
Other (OTH)
AF:
0.00130
AC:
2
AN:
1534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000763
Hom.:
6
Bravo
AF:
0.000423
EpiCase
AF:
0.000491
EpiControl
AF:
0.00136

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 29, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Sep 04, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 27, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
10
DANN
Benign
0.78
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148129382; hg19: chrX-53658558; API